Although the world is going through some tough economic times, there are companies that are posting astonishing growth. Fortune magazine has just come out with a list of fastest-growing companies in the world.
Let us take a look at them. All the figures are based on three-year average.
Courtesy: http://money.cnn.com/magazines/fortune/
Let us take a look at them. All the figures are based on three-year average.
1. SXC Health Solutions
Revenue Growth: 151%
Profit Growth: 65%
Total Return: 105%
SXC is both a pharmacy benefits manager (PBM) and a service provider to PBMs. With some $72 billion in branded drugs losing patent protection in the next five years, sales of generic alternatives are likely to rise. SXC's PBM unit, which acts as middleman between the insurance company and the pharmacy, could be the beneficiary: It makes more money each time a person uses a generic drug rather than a branded drug. Health care reform also means more people will be covered by Medicaid, which could benefit both of SXC's business lines.
SXC also stands to gain from growth in the use of specialty drugs like those for rheumatoid arthritis. SXC expanded its contract with one of its clients, HealthSpring, which focuses on specialty drugs, and acquired MedFusionRx, a specialty pharmacy provider, in December.
Get stock quote: SXCI
Revenue ($ millions): $2593.9
Net Income ($ millions): $68.2
Industry: Health Care
2. Green Mountain Coffee Roasters
Revenue Growth: 63%
Profit Growth: 69%
Total Return: 120%
Green Mountain is known as much for its K-cups, the single-serve coffee pods that are ubiquitous in corporate offices these days, as it is for its coffee. The company dominates the single-serve market and boasts customers such as ConAgra Foods, Starbucks, and Dunkin' Donuts, which use K-cups for hot cocoa, teas and coffees. Some 82% of company sales stem from the pod and the "Keurig Brewing System."
It's lucrative for Green Mountain, which charges the equivalent of $35 a pound for coffee in K-cups, according to Greg Fraser of the GRT Absolute Return fund. But Green Mountain faces the loss of patent protection for the K-Cups in 2012, which could crimp revenues and profits going forward.
Get stock quote: GMCR
Revenue ($ millions): $1912.4
Net Income ($ millions): $113
Industry: Beverages
Revenue Growth: 151%
Profit Growth: 65%
Total Return: 105%
SXC is both a pharmacy benefits manager (PBM) and a service provider to PBMs. With some $72 billion in branded drugs losing patent protection in the next five years, sales of generic alternatives are likely to rise. SXC's PBM unit, which acts as middleman between the insurance company and the pharmacy, could be the beneficiary: It makes more money each time a person uses a generic drug rather than a branded drug. Health care reform also means more people will be covered by Medicaid, which could benefit both of SXC's business lines.
SXC also stands to gain from growth in the use of specialty drugs like those for rheumatoid arthritis. SXC expanded its contract with one of its clients, HealthSpring, which focuses on specialty drugs, and acquired MedFusionRx, a specialty pharmacy provider, in December.
Get stock quote: SXCI
Revenue ($ millions): $2593.9
Net Income ($ millions): $68.2
Industry: Health Care
2. Green Mountain Coffee Roasters
Revenue Growth: 63%
Profit Growth: 69%
Total Return: 120%
Green Mountain is known as much for its K-cups, the single-serve coffee pods that are ubiquitous in corporate offices these days, as it is for its coffee. The company dominates the single-serve market and boasts customers such as ConAgra Foods, Starbucks, and Dunkin' Donuts, which use K-cups for hot cocoa, teas and coffees. Some 82% of company sales stem from the pod and the "Keurig Brewing System."
It's lucrative for Green Mountain, which charges the equivalent of $35 a pound for coffee in K-cups, according to Greg Fraser of the GRT Absolute Return fund. But Green Mountain faces the loss of patent protection for the K-Cups in 2012, which could crimp revenues and profits going forward.
Get stock quote: GMCR
Revenue ($ millions): $1912.4
Net Income ($ millions): $113
Industry: Beverages
3. Hi-Tech PharmacalRevenue Growth: 51%
Profit Growth: 234%
Total Return: 42%
This maker of generic drugs for allergies, diabetes and pain reported 51% sales gains in 2010 and has continued strong this year with a 45% year-over-year increase in the most recent quarter. The company-which specializes in liquid and spray drugs and makes a popular generic version of the allergy medication Flonase-seems poised for continued growth: It currently has 13 pending generics applications at the Food & Drug Adminstration, addressing more than $1 billion in name-brand drug sales in 2010, according to IMS Health. Besides its generics division, Hi-Tech has two other segments: The health care products division sells branded over-the-counter products. And a line of magnesium supplements, acquired in 2010, has also contributed to sales.
Get stock quote: HITK
Revenue ($ millions): $190.9
Net Income ($ millions): $41.5
Industry: Health Care
Profit Growth: 234%
Total Return: 42%
This maker of generic drugs for allergies, diabetes and pain reported 51% sales gains in 2010 and has continued strong this year with a 45% year-over-year increase in the most recent quarter. The company-which specializes in liquid and spray drugs and makes a popular generic version of the allergy medication Flonase-seems poised for continued growth: It currently has 13 pending generics applications at the Food & Drug Adminstration, addressing more than $1 billion in name-brand drug sales in 2010, according to IMS Health. Besides its generics division, Hi-Tech has two other segments: The health care products division sells branded over-the-counter products. And a line of magnesium supplements, acquired in 2010, has also contributed to sales.
Get stock quote: HITK
Revenue ($ millions): $190.9
Net Income ($ millions): $41.5
Industry: Health Care
See below for more information
Top 100
Courtesy: http://money.cnn.com/magazines/fortune/